News
FBIOP
6.35
+3.25%
0.20
Weekly Report: what happened at FBIOP last week (0428-0502)?
Weekly Report · 5d ago
Weekly Report: what happened at FBIOP last week (0421-0425)?
Weekly Report · 04/28 10:00
Weekly Report: what happened at FBIOP last week (0414-0418)?
Weekly Report · 04/21 10:00
Weekly Report: what happened at FBIOP last week (0407-0411)?
Weekly Report · 04/14 09:56
Weekly Report: what happened at FBIOP last week (0331-0404)?
Weekly Report · 04/07 09:55
FORTRESS BIOTECH, INC. ANNUAL REPORT ON FORM 10-K
Press release · 03/31 22:34
Fortress Biotech Inc reports results for the quarter ended December 31 - Earnings Summary
Reuters · 03/31 21:00
FORTRESS BIOTECH REPORTS 2024 FINANCIAL RESULTS AND RECENT CORPORATE HIGHLIGHTS
Reuters · 03/31 20:05
Weekly Report: what happened at FBIOP last week (0324-0328)?
Weekly Report · 03/31 10:00
Fortress Biotech Inc <FBIO.OQ> expected to post a loss of 75 cents a share - Earnings Preview
Reuters · 03/28 20:27
JOURNEY MEDICAL CORPORATION LAUNCHES EMROSI™ (40 MG MINOCYCLINE HYDROCHLORIDE MODIFIED-RELEASE CAPSULES, 10 MG IMMEDIATE RELEASE AND 30 MG EXTENDED RELEASE) FOR THE TREATMENT OF ROSACEA
Reuters · 03/24 12:30
Weekly Report: what happened at FBIOP last week (0317-0321)?
Weekly Report · 03/24 09:55
Fortress Biotech Inc <FBIO.OQ> expected to post a loss of 75 cents a share - Earnings Preview
Reuters · 03/21 12:09
JOURNEY MEDICAL CORPORATION TO ANNOUNCE YEAR END 2024 FINANCIAL RESULTS ON MARCH 26, 2025
Reuters · 03/19 20:01
Checkpoint Therapeutics Inc <CKPT.OQ> expected to post a loss of 19 cents a share - Earnings Preview
Reuters · 03/18 12:39
PARTEX AND FORTRESS BIOTECH ANNOUNCE STRATEGIC COLLABORATION TO ACCELERATE ASSET IDENTIFICATION AND EVALUATION USING PROPRIETARY AI PLATFORM
Reuters · 03/17 12:57
Weekly Report: what happened at FBIOP last week (0310-0314)?
Weekly Report · 03/17 09:59
Avenue Therapeutics Inc <ATXI.OQ> expected to post a loss of 57 cents a share - Earnings Preview
Reuters · 03/14 20:14
BUZZ-U.S. STOCKS ON THE MOVE-Willis Lease Finance, CME Group
Reuters · 03/10 16:12
Deals of the day-Mergers and acquisitions
Reuters · 03/10 13:39
More
Webull provides a variety of real-time FBIOP stock news. You can receive the latest news about Fortress Biotech Inc through multiple platforms. This information may help you make smarter investment decisions.
About FBIOP
More
Fortress Biotech, Inc. is a biopharmaceutical company focused on acquiring and advancing assets. The Company has eight marketed prescription pharmaceutical products and over 20 programs in development, with its majority-owned and majority-controlled partners and subsidiaries and partners and subsidiaries it founded and in which it holds significant minority ownership positions. Its portfolio is being commercialized and developed for various therapeutic areas, including oncology, dermatology, and rare diseases. Its dermatology products include Emrosi, Qbrexza, Amzeeq, Zilxi, Exelderm, Targadox, and Luxamend. Its late-stage product candidates include CUTX-101 (copper histidinate injection for Menkes disease), Triplex (cytomegalovirus (CMV) vaccine), and CAEL-101 (monoclonal antibody for AL amyloidosis). Its early and mid-stage product candidates include Dotinurad (urate transporter (URAT1) inhibitor for gout), MB-101 (IL13Rα2 CAR T Cell Program for Glioblastoma), and others.